(OVV) Ovintiv - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US69047Q1022
Stock: Oil, Natural Gas, NGLs
Total Rating 56
Risk 62
Buy Signal -0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -0.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 21.20 |
| Character TTM | |
|---|---|
| Beta | 1.082 |
| Beta Downside | 2.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.21% |
| CAGR/Max DD | 0.37 |
EPS (Earnings per Share)
Revenue
Description: OVV Ovintiv March 05, 2026
Ovintiv Inc. (OVV) is a North American oil and natural gas exploration and production company.
The company operates in key basins, including the Permian in West Texas and Anadarko in Oklahoma, which are significant shale plays in the US. It also has operations in Western Canada.
Ovintivs business model focuses on the full lifecycle of hydrocarbon extraction, from exploration and development to production and marketing of crude oil, natural gas, and natural gas liquids (NGLs).
For more detailed financial and operational insights, ValueRay offers comprehensive analysis.
Headlines to watch out for
- Global crude oil prices dictate OVVs revenue and profitability
- Natural gas price fluctuations impact Canadian segment earnings
- Regulatory changes on drilling permits affect operational costs
- Production volumes from Permian basin drive revenue growth
- Operating expenses and capital expenditures influence net income
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.24b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 10.39 > 1.0 |
| NWC/Revenue: -14.48% < 20% (prev -14.34%; Δ -0.14% < -1%) |
| CFO/TA 0.18 > 3% & CFO 3.62b > Net Income 1.24b |
| Net Debt (7.49b) to EBITDA (3.34b): 2.25 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (259.7m) vs 12m ago -0.23% < -2% |
| Gross Margin: 47.09% > 18% (prev 0.54%; Δ 4655 % > 0.5%) |
| Asset Turnover: 44.33% > 50% (prev 47.53%; Δ -3.20% > 0%) |
| Interest Coverage Ratio: 3.06 > 6 (EBITDA TTM 3.34b / Interest Expense TTM 374.0m) |
Altman Z'' 0.76
| A: -0.06 (Total Current Assets 1.52b - Total Current Liabilities 2.79b) / Total Assets 20.39b |
| B: 0.12 (Retained Earnings 2.44b / Total Assets 20.39b) |
| C: 0.06 (EBIT TTM 1.14b / Avg Total Assets 19.82b) |
| D: 0.37 (Book Value of Equity 3.42b / Total Liabilities 9.20b) |
| Altman-Z'' Score: 0.76 = B |
Beneish M -2.86
| DSRI: 1.07 (Receivables 1.16b/1.12b, Revenue 8.79b/9.15b) |
| GMI: 1.16 (GM 47.09% / 54.45%) |
| AQI: 1.19 (AQ_t 0.17 / AQ_t-1 0.14) |
| SGI: 0.96 (Revenue 8.79b / 9.15b) |
| TATA: -0.12 (NI 1.24b - CFO 3.62b) / TA 20.39b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of OVV shares?
As of March 11, 2026, the stock is trading at USD 52.90 with a total of 6,608,340 shares traded.
Over the past week, the price has changed by +2.14%, over one month by +13.45%, over three months by +27.93% and over the past year by +44.04%.
Over the past week, the price has changed by +2.14%, over one month by +13.45%, over three months by +27.93% and over the past year by +44.04%.
Is OVV a buy, sell or hold?
Ovintiv has received a consensus analysts rating of 4.26.
Therefore, it is recommended to buy OVV.
- StrongBuy: 11
- Buy: 7
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OVV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57 | 7.8% |
| Analysts Target Price | 57 | 7.8% |
OVV Fundamental Data Overview March 08, 2026
P/E Trailing = 11.0232
P/E Forward = 10.6952
P/S = 1.7089
P/B = 1.309
P/EG = 1.8514
Revenue TTM = 8.79b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 3.34b USD
Long Term Debt = 4.39b USD (from longTermDebt, last quarter)
Short Term Debt = 927.0m USD (from shortTermDebt, last quarter)
Debt = 7.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.49b USD (from netDebt column, last quarter)
Enterprise Value = 22.05b USD (14.80b + Debt 7.53b - CCE 280.0m)
Interest Coverage Ratio = 3.06 (Ebit TTM 1.14b / Interest Expense TTM 374.0m)
EV/FCF = 6.09x (Enterprise Value 22.05b / FCF TTM 3.62b)
FCF Yield = 16.42% (FCF TTM 3.62b / Enterprise Value 22.05b)
FCF Margin = 41.20% (FCF TTM 3.62b / Revenue TTM 8.79b)
Net Margin = 14.13% (Net Income TTM 1.24b / Revenue TTM 8.79b)
Gross Margin = 47.09% ((Revenue TTM 8.79b - Cost of Revenue TTM 4.65b) / Revenue TTM)
Gross Margin QoQ = 26.45% (prev 49.41%)
Tobins Q-Ratio = 1.08 (Enterprise Value 22.05b / Total Assets 20.39b)
Interest Expense / Debt = 1.24% (Interest Expense 93.0m / Debt 7.53b)
Taxrate = 21.0% (US default 21%)
NOPAT = 903.8m (EBIT 1.14b * (1 - 21.00%))
Current Ratio = 0.54 (Total Current Assets 1.52b / Total Current Liabilities 2.79b)
Debt / Equity = 0.67 (Debt 7.53b / totalStockholderEquity, last quarter 11.20b)
Debt / EBITDA = 2.25 (Net Debt 7.49b / EBITDA 3.34b)
Debt / FCF = 2.07 (Net Debt 7.49b / FCF TTM 3.62b)
Total Stockholder Equity = 10.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 1.24b / Total Assets 20.39b)
RoE = 11.86% (Net Income TTM 1.24b / Total Stockholder Equity 10.47b)
RoCE = 7.70% (EBIT 1.14b / Capital Employed (Equity 10.47b + L.T.Debt 4.39b))
RoIC = 5.72% (NOPAT 903.8m / Invested Capital 15.79b)
WACC = 6.89% (E(14.80b)/V(22.33b) * Re(9.90%) + D(7.53b)/V(22.33b) * Rd(1.24%) * (1-Tc(0.21)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.73%
[DCF] Terminal Value 81.82% ; FCFF base≈2.74b ; Y1≈2.63b ; Y5≈2.57b
[DCF] Fair Price = 178.7 (EV 58.12b - Net Debt 7.49b = Equity 50.63b / Shares 283.3m; r=6.89% [WACC]; 5y FCF grow -5.21% → 2.90% )
EPS Correlation: -34.76 | EPS CAGR: -11.20% | SUE: 1.42 | # QB: 1
Revenue Correlation: -59.43 | Revenue CAGR: 1.40% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.91 | Chg7d=+0.000 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=6
EPS current Year (2026-12-31): EPS=4.85 | Chg7d=+0.294 | Chg30d=+0.508 | Revisions Net=-1 | Growth EPS=+0.2% | Growth Revenue=-4.5%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=+0.159 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=+20.4% | Growth Revenue=+11.2%
[Analyst] Revisions Ratio: -0.14 (3 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 9.9% - Earnings Yield 9.1%)
[Growth] Growth Spread = -23.6% (Analyst -22.7% - Implied 0.8%)
P/E Forward = 10.6952
P/S = 1.7089
P/B = 1.309
P/EG = 1.8514
Revenue TTM = 8.79b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 3.34b USD
Long Term Debt = 4.39b USD (from longTermDebt, last quarter)
Short Term Debt = 927.0m USD (from shortTermDebt, last quarter)
Debt = 7.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.49b USD (from netDebt column, last quarter)
Enterprise Value = 22.05b USD (14.80b + Debt 7.53b - CCE 280.0m)
Interest Coverage Ratio = 3.06 (Ebit TTM 1.14b / Interest Expense TTM 374.0m)
EV/FCF = 6.09x (Enterprise Value 22.05b / FCF TTM 3.62b)
FCF Yield = 16.42% (FCF TTM 3.62b / Enterprise Value 22.05b)
FCF Margin = 41.20% (FCF TTM 3.62b / Revenue TTM 8.79b)
Net Margin = 14.13% (Net Income TTM 1.24b / Revenue TTM 8.79b)
Gross Margin = 47.09% ((Revenue TTM 8.79b - Cost of Revenue TTM 4.65b) / Revenue TTM)
Gross Margin QoQ = 26.45% (prev 49.41%)
Tobins Q-Ratio = 1.08 (Enterprise Value 22.05b / Total Assets 20.39b)
Interest Expense / Debt = 1.24% (Interest Expense 93.0m / Debt 7.53b)
Taxrate = 21.0% (US default 21%)
NOPAT = 903.8m (EBIT 1.14b * (1 - 21.00%))
Current Ratio = 0.54 (Total Current Assets 1.52b / Total Current Liabilities 2.79b)
Debt / Equity = 0.67 (Debt 7.53b / totalStockholderEquity, last quarter 11.20b)
Debt / EBITDA = 2.25 (Net Debt 7.49b / EBITDA 3.34b)
Debt / FCF = 2.07 (Net Debt 7.49b / FCF TTM 3.62b)
Total Stockholder Equity = 10.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 1.24b / Total Assets 20.39b)
RoE = 11.86% (Net Income TTM 1.24b / Total Stockholder Equity 10.47b)
RoCE = 7.70% (EBIT 1.14b / Capital Employed (Equity 10.47b + L.T.Debt 4.39b))
RoIC = 5.72% (NOPAT 903.8m / Invested Capital 15.79b)
WACC = 6.89% (E(14.80b)/V(22.33b) * Re(9.90%) + D(7.53b)/V(22.33b) * Rd(1.24%) * (1-Tc(0.21)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.73%
[DCF] Terminal Value 81.82% ; FCFF base≈2.74b ; Y1≈2.63b ; Y5≈2.57b
[DCF] Fair Price = 178.7 (EV 58.12b - Net Debt 7.49b = Equity 50.63b / Shares 283.3m; r=6.89% [WACC]; 5y FCF grow -5.21% → 2.90% )
EPS Correlation: -34.76 | EPS CAGR: -11.20% | SUE: 1.42 | # QB: 1
Revenue Correlation: -59.43 | Revenue CAGR: 1.40% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.91 | Chg7d=+0.000 | Chg30d=-0.040 | Revisions Net=-1 | Analysts=6
EPS current Year (2026-12-31): EPS=4.85 | Chg7d=+0.294 | Chg30d=+0.508 | Revisions Net=-1 | Growth EPS=+0.2% | Growth Revenue=-4.5%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=+0.159 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=+20.4% | Growth Revenue=+11.2%
[Analyst] Revisions Ratio: -0.14 (3 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 9.9% - Earnings Yield 9.1%)
[Growth] Growth Spread = -23.6% (Analyst -22.7% - Implied 0.8%)